Axial Podcast
Conversations with great founders and inventors in life sciences.
Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio and Seranova Bio often when they are no more than an idea. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company. We are excited to be in business with you - email us at info@axialvc.com
Read our newsletter: https://axial.substack.com/
Latest episodes
Mar 23, 2025 • 50min
Modern Computational Tools for Chemistry with Corin Wagen
Corin Wagen is the Founder and CEO of Rowan. During our conversation, we talk about Corin's journey from the Jacobsen Lab at Harvard to starting Rowan with his brother. Rowan builds design and simulation software for chemistry. The company uses machine learning on quantum mechanics data to predict molecular interactions with high accuracy. Rowan trains its models on internal data and information from publicly available datasets. The key part of the product is reducing the time to make these predictions. Legacy, often on-prem, software can take weeks of computing to calculate, say the pKa or redox potential of a compound. Rowan uses machine learning to speed up these predictions with comparable accuracy.Rowan’s vision is to make their tools accessible to all types of chemists and scientists, not just experts in particular areas of computational chemistry. Making computational chemistry as easy to use as Uber, Venmo, or ChatGPT. Simplifying complex calculations like reaction prediction, property estimation, and data analysis. With 100s of chemists using Rowan.
Mar 23, 2025 • 51min
Evolutionary Intelligence and Biologics Discovery with Jeremy Agresti
Jeremy Agresti is the Founder and CTO of Triplebar Bio.
Mar 23, 2025 • 58min
AI Workflows for Biopharma with Alex Telford
In this engaging discussion, Alex Telford, Co-founder and CEO of Convoke, dives into the pivotal role of forecasting in biopharma development, emphasizing its strategic importance in preclinical stages. He also highlights the transformative potential of technology, such as natural language processing, to reshape data analysis and improve collaboration in the industry. Alex shares insights on bridging the gap between biotech and tech cultures, the necessity of a writing culture in growing companies, and the value of diverse reading habits for industry professionals.
Mar 22, 2025 • 56min
AI Legal Software with Scott Stevenson
Scott Stevenson is the Co-Founder and CEO of Spellbook.
Mar 22, 2025 • 1h
Scaling Proteomics with Milad Dagher
Milad Dagher is the Co-Founder and CEO of Nomic Bio.
Mar 22, 2025 • 57min
Proteomics and AI with Peter Cimermančič
Peter Cimermančič is the Co-Founder and CEO of Tesorai.
Mar 22, 2025 • 49min
Computational Protein Design with Costas Maranas
Costas Maranas is a Professor of Chemical Engineering at Penn State.
Mar 22, 2025 • 52min
Patents, AI, and Business Intelligence Software with Simeon Graupe
Simeon Graupe is the Co-Founder and CEO of PatentPlus.
Mar 22, 2025 • 48min
R&D Partnering with Kevin Leland
Kevin Leland is the Founder and CEO of Halo Science.
Mar 22, 2025 • 1h 8min
Analysis of Clinical Trials with Spencer Hey
Spencer Hey is the Co-Founder and Chief Scientific Officer of Prism Analytic Technologies.
